Antiangiogenic therapies in breast cancer

Roberta Sarmiento, Mario Rosario D'Andrea, Francesca Cacciamani, Francesca Salerno, Giampietro Gasparini

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Angiogenesis is a complex, multistep process that is involved in the progression and prognosis of several types of cancer. In particular, it has been demonstrated that angiogenesis plays a central role in the progression of breast cancer. This review evaluates results from clinical trials in which the efficacy of conventional chemotherapeutic agents was compared with that of novel antiangiogenic compounds for the treatment of breast cancer, and provides a summary of trials that were ongoing at the time of publication in the neoadjuvant and adjuvant settings.

Original languageEnglish
Pages (from-to)1334-1345
Number of pages12
JournalCurrent Opinion in Investigational Drugs
Volume10
Issue number12
Publication statusPublished - Dec 2009

Fingerprint

Breast Neoplasms
Publications
Clinical Trials
Therapeutics
Neoplasms

Keywords

  • Angiogenesis
  • Bevacizumab
  • Breast cancer
  • Tyrosine kinase inhibitor
  • VEGF

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Sarmiento, R., D'Andrea, M. R., Cacciamani, F., Salerno, F., & Gasparini, G. (2009). Antiangiogenic therapies in breast cancer. Current Opinion in Investigational Drugs, 10(12), 1334-1345.

Antiangiogenic therapies in breast cancer. / Sarmiento, Roberta; D'Andrea, Mario Rosario; Cacciamani, Francesca; Salerno, Francesca; Gasparini, Giampietro.

In: Current Opinion in Investigational Drugs, Vol. 10, No. 12, 12.2009, p. 1334-1345.

Research output: Contribution to journalArticle

Sarmiento, R, D'Andrea, MR, Cacciamani, F, Salerno, F & Gasparini, G 2009, 'Antiangiogenic therapies in breast cancer', Current Opinion in Investigational Drugs, vol. 10, no. 12, pp. 1334-1345.
Sarmiento R, D'Andrea MR, Cacciamani F, Salerno F, Gasparini G. Antiangiogenic therapies in breast cancer. Current Opinion in Investigational Drugs. 2009 Dec;10(12):1334-1345.
Sarmiento, Roberta ; D'Andrea, Mario Rosario ; Cacciamani, Francesca ; Salerno, Francesca ; Gasparini, Giampietro. / Antiangiogenic therapies in breast cancer. In: Current Opinion in Investigational Drugs. 2009 ; Vol. 10, No. 12. pp. 1334-1345.
@article{558d750e4378401bb2ed82f8c07aa6d1,
title = "Antiangiogenic therapies in breast cancer",
abstract = "Angiogenesis is a complex, multistep process that is involved in the progression and prognosis of several types of cancer. In particular, it has been demonstrated that angiogenesis plays a central role in the progression of breast cancer. This review evaluates results from clinical trials in which the efficacy of conventional chemotherapeutic agents was compared with that of novel antiangiogenic compounds for the treatment of breast cancer, and provides a summary of trials that were ongoing at the time of publication in the neoadjuvant and adjuvant settings.",
keywords = "Angiogenesis, Bevacizumab, Breast cancer, Tyrosine kinase inhibitor, VEGF",
author = "Roberta Sarmiento and D'Andrea, {Mario Rosario} and Francesca Cacciamani and Francesca Salerno and Giampietro Gasparini",
year = "2009",
month = "12",
language = "English",
volume = "10",
pages = "1334--1345",
journal = "Current Opinion in Investigational Drugs",
issn = "1472-4472",
publisher = "Current Drugs Ltd.",
number = "12",

}

TY - JOUR

T1 - Antiangiogenic therapies in breast cancer

AU - Sarmiento, Roberta

AU - D'Andrea, Mario Rosario

AU - Cacciamani, Francesca

AU - Salerno, Francesca

AU - Gasparini, Giampietro

PY - 2009/12

Y1 - 2009/12

N2 - Angiogenesis is a complex, multistep process that is involved in the progression and prognosis of several types of cancer. In particular, it has been demonstrated that angiogenesis plays a central role in the progression of breast cancer. This review evaluates results from clinical trials in which the efficacy of conventional chemotherapeutic agents was compared with that of novel antiangiogenic compounds for the treatment of breast cancer, and provides a summary of trials that were ongoing at the time of publication in the neoadjuvant and adjuvant settings.

AB - Angiogenesis is a complex, multistep process that is involved in the progression and prognosis of several types of cancer. In particular, it has been demonstrated that angiogenesis plays a central role in the progression of breast cancer. This review evaluates results from clinical trials in which the efficacy of conventional chemotherapeutic agents was compared with that of novel antiangiogenic compounds for the treatment of breast cancer, and provides a summary of trials that were ongoing at the time of publication in the neoadjuvant and adjuvant settings.

KW - Angiogenesis

KW - Bevacizumab

KW - Breast cancer

KW - Tyrosine kinase inhibitor

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=71249123237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71249123237&partnerID=8YFLogxK

M3 - Article

C2 - 19943205

AN - SCOPUS:71249123237

VL - 10

SP - 1334

EP - 1345

JO - Current Opinion in Investigational Drugs

JF - Current Opinion in Investigational Drugs

SN - 1472-4472

IS - 12

ER -